Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Efficacy Testing
About this study
This protocol describes pilot testing of an educational shared decision-making intervention to help men with localized prostate cancer make decisions with their health care providers about if and when to de-escalate surveillance testing. The project is important because for many patients their cancer does not progress to the point of needed curative treatment or their health status changes such that they are no longer good candidates for treatment. For these men, de-escalating ongoing surveillance (e.g., fewer biopsies or imaging studies) is a reasonable option.
- Condition
- Prostate Cancer
- Sponsor
- M.D. Anderson Cancer Center
Who can join
- Age
- 65 years and older
- Sex
- Male only
- Healthy volunteers
- Not accepted
Inclusion 11
- Minimum age: 65 years
- Eligible sex: Male
- Study condition: Prostate Cancer
- Patients:
- Males aged 65 or older
- Diagnosis of localized prostate cancer
- Have not received curative intent treatment for their prostate cancer
- Fluent in English
- Care partners/caregivers:
- Aged 18 or older
- Involved with the care of an eligible patient (i.e. partner, close friend, family member, companion)
Exclusion 4
- Patients
- \. Currently receiving treatment for another cancer (primary or recurrence)
- Care partners/caregivers
- \. None
Where
1 site, 1 recruiting
M.D. Anderson Cancer Center
Houston, Texas, United States
Contact
-
Lisa Lowenstein, MD
713-563-0020 deescalatepca@mdanderson.org
Potential match only. Final eligibility is determined by the study team.